IDEAYA Biosciences (IDYA) Income towards Parent Company (2020 - 2025)
Historic Income towards Parent Company for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to -$94.6 million.
- IDEAYA Biosciences' Income towards Parent Company rose 3438.93% to -$94.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.9 million, marking a year-over-year increase of 10424.56%. This contributed to the annual value of -$159.3 million for FY2025, which is 5127.67% up from last year.
- Latest data reveals that IDEAYA Biosciences reported Income towards Parent Company of -$94.6 million as of Q4 2025, which was up 3438.93% from $108.5 million recorded in Q3 2025.
- IDEAYA Biosciences' Income towards Parent Company's 5-year high stood at $108.5 million during Q3 2025, with a 5-year trough of -$144.1 million in Q4 2024.
- Its 5-year average for Income towards Parent Company is -$31.1 million, with a median of -$26.4 million in 2022.
- Its Income towards Parent Company has fluctuated over the past 5 years, first tumbled by 517969.7% in 2023, then surged by 26212.76% in 2025.
- Quarter analysis of 5 years shows IDEAYA Biosciences' Income towards Parent Company stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then skyrocketed by 34.39% to -$94.6 million in 2025.
- Its Income towards Parent Company was -$94.6 million in Q4 2025, compared to $108.5 million in Q3 2025 and -$144.1 million in Q4 2024.